Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avalyn Pharma Inc. - common stock
(NQ:
AVLN
)
34.69
-1.82 (-4.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
202,894
Open
36.45
Bid (Size)
25.00 (100)
Ask (Size)
44.50 (100)
Prev. Close
36.51
Today's Range
34.37 - 36.45
52wk Range
24.15 - 40.17
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
August 24, 2026
Presentations describe integration of patient perspective into clinical trial design and data modeling AP01 distribution in the lungs
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Performance
YTD
+17.6%
+17.6%
1 Month
+18.4%
+18.4%
3 Month
+30.1%
+30.1%
6 Month
+17.6%
+17.6%
1 Year
+17.6%
+17.6%
More News
Read More
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
June 17, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
↗
June 05, 2026
Via
MarketBeat
Topics
Initial Public Offering
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
June 03, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
May 21, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
May 05, 2026
From
Avalyn Pharma Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Avalyn Pharma Inc. - common stock publicly traded?
Yes, Avalyn Pharma Inc. - common stock is publicly traded.
What exchange does Avalyn Pharma Inc. - common stock trade on?
Avalyn Pharma Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalyn Pharma Inc. - common stock?
The ticker symbol for Avalyn Pharma Inc. - common stock is AVLN on the Nasdaq Stock Market
What is the current price of Avalyn Pharma Inc. - common stock?
The current price of Avalyn Pharma Inc. - common stock is 34.69
When was Avalyn Pharma Inc. - common stock last traded?
The last trade of Avalyn Pharma Inc. - common stock was at 08/28/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.